Journal article
1121: The Cytoprotective Chaperone, Clusterin, is Associated with Docetaxel-Resistance in Prostate Cancer Cell Lines: Implications in Second-Line Strategies for Metastatic HRPC
Authors
Sowery RD; Hadaschik BA; Fazli L; Ettinger S; So AI; Gleave ME
Journal
Journal of Urology, Vol. 177, No. 4,
Publisher
Wolters Kluwer
Publication Date
April 1, 2007
DOI
10.1016/s0022-5347(18)31335-1
ISSN
0021-0005